Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.

Détails

ID Serval
serval:BIB_9CABCFD8F19E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Périodique
Clinical microbiology and infection
Auteur⸱e⸱s
Orasch C., Marchetti O., Garbino J., Schrenzel J., Zimmerli S., Mühlethaler K., Pfyffer G., Ruef C., Fehr J., Zbinden R., Calandra T., Bille J.
Collaborateur⸱rice⸱s
FUNGINOS
Contributeur⸱rice⸱s
Bregenzer T., Fluckiger U., Heininger U., Hertel R., Franciolli M., Dolina M., Rothen M., Dubuis O., Tarr P., Fleisch F., Risch M., Ritzler E., Chuard C., Erard V., Fracheboud D., Emonet S., Genne D., Lienhardt R., Chave J.P., Andreutti-Zaugg C., Gallusser A., Monotti R., Bernasconi E., Krause M., Herzog K., Piso R.J., Schibli U., Bally F., Troillet N., Tissiere L., Boggian K., Bruderer T., Gubler J., Eich G., Graber P., Graf S., Conen A., Fankhauser H., Khanna N., Frei R., Berger C.
ISSN
1469-0691 (Electronic)
ISSN-L
1198-743X
Statut éditorial
Publié
Date de publication
07/2014
Peer-reviewed
Oui
Volume
20
Numéro
7
Pages
698-705
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
We analyzed the species distribution of Candida blood isolates (CBIs), prospectively collected between 2004 and 2009 within FUNGINOS, and compared their antifungal susceptibility according to clinical breakpoints defined by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) in 2013, and the Clinical and Laboratory Standards Institute (CLSI) in 2008 (old CLSI breakpoints) and 2012 (new CLSI breakpoints). CBIs were tested for susceptiblity to fluconazole, voriconazole and caspofungin by microtitre broth dilution (Sensititre® YeastOne™ test panel). Of 1090 CBIs, 675 (61.9%) were C. albicans, 191 (17.5%) C. glabrata, 64 (5.9%) C. tropicalis, 59 (5.4%) C. parapsilosis, 33 (3%) C. dubliniensis, 22 (2%) C. krusei and 46 (4.2%) rare Candida species. Independently of the breakpoints applied, C. albicans was almost uniformly (>98%) susceptible to all three antifungal agents. In contrast, the proportions of fluconazole- and voriconazole-susceptible C. tropicalis and F-susceptible C. parapsilosis were lower according to EUCAST/new CLSI breakpoints than to the old CLSI breakpoints. For caspofungin, non-susceptibility occurred mainly in C. krusei (63.3%) and C. glabrata (9.4%). Nine isolates (five C. tropicalis, three C. albicans and one C. parapsilosis) were cross-resistant to azoles according to EUCAST breakpoints, compared with three isolates (two C. albicans and one C. tropicalis) according to new and two (2 C. albicans) according to old CLSI breakpoints. Four species (C. albicans, C. glabrata, C. tropicalis and C. parapsilosis) represented >90% of all CBIs. In vitro resistance to fluconazole, voriconazole and caspofungin was rare among C. albicans, but an increase of non-susceptibile isolates was observed among C. tropicalis/C. parapsilosis for the azoles and C. glabrata/C. krusei for caspofungin according to EUCAST and new CLSI breakpoints compared with old CLSI breakpoints.
Mots-clé
Antifungal Agents/pharmacology, Candida/classification, Candida/drug effects, Candida/isolation & purification, Candidemia/epidemiology, Candidemia/microbiology, Caspofungin, Drug Resistance, Fungal, Echinocandins/pharmacology, Fluconazole/pharmacology, Lipopeptides, Microbial Sensitivity Tests, Prospective Studies, Switzerland/epidemiology, Voriconazole/pharmacology, Breakpoint, Candida, Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing, candidaemia, resistance, species
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/09/2014 18:18
Dernière modification de la notice
25/02/2022 7:36
Données d'usage